3 free views remaining today

amyotrophic lateral sclerosis

ICD-10 Codes

Related ICD-10:

Description

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects the motor neurons in the brain and spinal cord [1]. This results in muscle weakness and atrophy, eventually leading to respiratory failure and death [8].

The disease is characterized by the degeneration of nerve cells called neurons in the brain and spinal cord, which disrupts communication between the nervous system and muscles [2][7]. As a result, people with ALS experience progressive muscle weakness, starting with symptoms such as muscle twitching, cramping, or stiffness [3][5].

ALS is a rare disease, affecting approximately 2-3 per 100,000 people worldwide [6]. The exact cause of the disease remains unknown, but research suggests that it may be related to genetic mutations, environmental factors, and other underlying conditions [4].

Treatment options for ALS are limited, and the disease is ultimately fatal. However, various medications and therapies can help slow down the progression of symptoms and improve quality of life [9].

Additional Characteristics

  • Muscle weakness and atrophy
  • Limited treatment options
  • Progressive neurodegenerative disorder
  • Degeneration of nerve cells called neurons in the brain and spinal cord
  • Respiratory failure and death
  • Muscle twitching, cramping, or stiffness
  • Rare disease affecting approximately 2-3 per 100,000 people worldwide
  • Slowing down the progression of symptoms and improving quality of life

Signs and Symptoms

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and eventually death.

Common Signs and Symptoms:

  • Muscle weakness or twitching, particularly in the arms, legs, face, or tongue [1]
  • Difficulty walking or maintaining balance, which can lead to falls [1]
  • Weakness or clumsiness in the hands, making it difficult to perform daily activities [2]
  • Slurred speech or difficulty swallowing due to muscle weakness in the mouth and throat area [3]
  • Muscle cramps, spasms, or fasciculations (twitching) in the affected muscles [4]
  • Difficulty chewing or swallowing food and liquids [5]
  • Constipation, bloating, and urinary urgency can occur as the disease progresses [6]

Progression of Symptoms:

As ALS advances, muscle weakness and paralysis spread to other parts of the body. This can lead to:

  • Respiratory problems due to weakened diaphragm muscles
  • Difficulty speaking or swallowing
  • Loss of motor function in the arms, legs, and other areas

Early Detection is Key:

While there is no cure for ALS, early detection and diagnosis are crucial for managing symptoms and improving quality of life. If you or someone you know is experiencing any of these signs and symptoms, consult a healthcare professional promptly.

References:

[1] Context result 1 [2] Context result 9 [3] Context result 2 [4] Context result 6 [5] Context result 4 [6] Context result 5

Additional Symptoms

  • Difficulty walking or maintaining balance
  • Slurred speech or difficulty swallowing
  • Muscle weakness or twitching
  • Muscle cramps, spasms, or fasciculations
  • Difficulty chewing or swallowing food and liquids
  • Constipation, bloating, and urinary urgency
  • weakness

Diagnostic Tests

Diagnosing Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Overview

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and atrophy. Diagnosing ALS can be challenging, as there is no single test that can definitively confirm the condition. However, a combination of clinical examinations, laboratory tests, and electrodiagnostic studies can help establish a diagnosis.

Clinical Examination

A healthcare provider will conduct a thorough physical examination to assess muscle strength, reflexes, and other neurological functions [3]. This examination may reveal signs such as muscle weakness, wasting, or fasciculations (muscle twitches) [4].

Laboratory Tests

Blood and urine tests can help rule out other conditions that may mimic ALS symptoms [1][2]. These tests may include:

  • Blood tests to look for evidence of other diseases whose symptoms are similar to early signs of ALS
  • Genetic testing to identify genetic mutations associated with familial ALS

Electrodiagnostic Tests

Electromyography (EMG) and nerve conduction study (NCS) evaluate muscle and nerve functions, respectively [5]. These tests can help detect abnormalities in muscle and nerve function, which are characteristic of ALS.

Other Diagnostic Tests

Additional tests may be performed to rule out other conditions or to assess the progression of ALS. These include:

  • MRI scans to visualize changes in the brain and spinal cord
  • Muscle and nerve biopsies to examine tissue samples for signs of damage
  • Spinal tap (lumbar puncture) to collect cerebrospinal fluid for analysis

Diagnosis through Exclusion

ALS is typically diagnosed by excluding other conditions that may cause similar symptoms [7]. A healthcare provider will consider a range of factors, including medical history, physical examination findings, and laboratory test results, to establish a diagnosis.

References:

[1] Apr 10, 2024 — Blood and urine tests. Analyzing samples of your blood and urine in the laboratory might help eliminate other possible causes of your symptoms. [2] Aug 1, 2018 — Blood and Urine Tests: Blood tests are used to look for evidence of other diseases whose symptoms are similar to early signs of ALS. [3] Jul 19, 2024 — There is no single test that can definitely diagnose ALS. A healthcare provider will conduct a physical exam and review the person's full medical history. [4] It's only through a clinical examination and series of diagnostic tests, often ruling out other diseases that mimic ALS, that a diagnosis can be established. [5] Electrodiagnostic tests (EMG/NCS): Electomyography (EMG) and nerve conduction study (NCS) evaluates muscle and nerve functions. Specific abnormalities in the EMG and NCS results are characteristic of ALS. [6] To diagnose ALS, an NYU Langone specialist first asks about your medical history and performs a physical exam to obtain a complete picture of your health. [7] by I Štětkářová · 2021 · Cited by 46 — The diagnosis of ALS is determined by excluding other conditions and utilizing clinical examinations, laboratory and genetic tests and nerve conduction/needle electromyography.

Additional Diagnostic Tests

  • Blood tests
  • MRI scans
  • Genetic testing
  • Spinal tap (lumbar puncture)
  • Electromyography (EMG)
  • Nerve conduction study (NCS)
  • Muscle and nerve biopsies

Treatment

Treatment Options for Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects the nerve cells responsible for controlling voluntary muscle movement. While there is no cure for ALS, various drug treatments can help manage symptoms and slow down disease progression.

  • Riluzole: This is the first medication to show efficacy in extending life in ALS patients [6]. Riluzole works by blocking the release of glutamate, a neurotransmitter that can be toxic to nerve cells. Studies have shown that riluzole can delay the initiation of respiratory dysfunction and extend median survival in patients with ALS [2].
  • Edaravone (Radicava): This medication may reduce the speed of decline in daily functioning in ALS patients [1]. Edaravone is administered through a vein or by mouth, and its exact mechanism of action is not fully understood.
  • Antispasticity agents: Baclofen (Lioresal) and tizanidine (Zanaflex) can be used to treat limb stiffness, which is a common symptom in ALS patients [3]. Baclofen can be started at 10 mg/day and titrated as needed.

Newer Treatments

  • Qalsody (tofersen): This medication was approved by the FDA in April 2023 for the treatment of ALS associated with a mutation in the superoxide dismutase 1 (SOD1) gene [5]. Qalsody works by targeting the SOD1 protein, which is implicated in the pathogenesis of ALS.
  • Radicava ORS: This oral suspension formulation of edaravone was approved by the FDA in May 2022 for the treatment of adults with ALS [7].

Important Considerations

While these drug treatments can help manage symptoms and slow down disease progression, it's essential to note that each patient's experience with ALS is unique. Treatment decisions should be made in consultation with a healthcare provider, taking into account individual factors such as disease severity, overall health, and personal preferences.

References:

[1] Apr 10, 2024 — Edaravone (Radicava). This medicine may reduce the speed of decline in daily functioning. It's given through a vein in your arm or by mouth as a ...

[2] by H Lu · 2016 · Cited by 71 — Riluzole, used for the treatment of ALS, was demonstrated to slightly delay the initiation of respiratory dysfunction and extend the median survival of patients ...

[3] Apr 11, 2024 — Limb stiffness can be treated with the antispasticity agents baclofen (Lioresal) and tizanidine (Zanaflex). Baclofen can be started at 10 mg/day ...

[5] Apr 25, 2023 — FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene.

[6] Apr 11, 2024 — The glutamate pathway antagonist riluzole is the first medication that has shown efficacy in extending life in amyotrophic lateral sclerosis ( ...

[7] May 12, 2022 — FDA has approved Radicava ORS (edaravone) oral suspension for the treatment of adults with amyotrophic lateral sclerosis (ALS).

Recommended Medications

  • Qalsody (tofersen)
  • Antispasticity agents: Baclofen (Lioresal), tizanidine (Zanaflex)
  • Radicava ORS
  • Riluzole
  • edaravone

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis of amyotrophic lateral sclerosis (ALS) involves identifying other conditions that may present with similar symptoms to ALS. Here are some conditions that should be considered in the differential diagnosis of ALS:

  • Benign fasciculation syndrome: This is a condition characterized by muscle twitching and weakness, but it does not progress to paralysis like ALS [1].
  • Multifocal motor neuropathy: This is a rare neurological disorder that affects the nerves controlling voluntary muscles, leading to muscle weakness and atrophy [3].
  • Neuralgic amyotrophy: Also known as brachial neuritis, this condition causes sudden onset of severe pain and weakness in one or more limbs [3].
  • Bulbospinal muscular atrophy (Kennedy's disease): This is a rare genetic disorder that affects the motor neurons, leading to muscle weakness and wasting, particularly in the arms and legs [4].
  • Chronic inflammatory demyelinating polyneuropathy (CIDP): This is an autoimmune disorder that causes damage to the nerves, leading to muscle weakness and atrophy [3].
  • Myasthenia gravis: This is a chronic autoimmune disorder that affects the nerve-muscle connection, leading to muscle weakness and fatigue [7].
  • Syringobulbia: This is a rare condition characterized by the formation of a fluid-filled cavity in the brainstem, which can cause symptoms similar to ALS [7].
  • Primary lateral sclerosis (PLS): This is a rare degenerative disorder that affects the upper motor neurons, leading to muscle weakness and spasticity [12].

It's essential to note that these conditions may have overlapping symptoms with ALS, making accurate diagnosis challenging. A comprehensive diagnostic workup, including clinical evaluation, laboratory tests, and imaging studies, is necessary to rule out other conditions and confirm a diagnosis of ALS.

References:

[1] Singh et al. (review article) [3] [3] Mitsumoto et al. (1997) [4] [4] de Carvalho et al. (2024) [7] [7] Walling et al. (1999) [12] Escorial criteria for ALS diagnosis

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
UMLS_CUI:C0002736
core#exactMatch
MESH:D000690
oboInOwl#id
DOID:332
core#notation
DOID:332
IAO_0000115
A motor neuron disease that is characterized by muscle spasticity, rapidly progressive weakness due to muscle atrophy, difficulty in speaking, swallowing, and breathing.
oboInOwl#hasExactSynonym
motor neuron disease, bulbar
rdf-schema#label
amyotrophic lateral sclerosis
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0111227
relatedICD
http://example.org/icd10/G12.21
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_3035
RO_0003304
http://purl.obolibrary.org/obo/MIM_617921
owl#annotatedSource
t423018
owl#someValuesFrom
t4020712

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.